Alagille Syndrome Treatment The global Alagille Syndrome Treatment Market focuses on therapies aimed at managing the symptoms and complications of Alagille Syndrome (ALGS), a rare, multi-system genetic disorder caused primarily by mutations in the JAG1 gene. ALGS is characterized by abnormalities in the liver, heart, eyes, skeleton, and kidneys, with the most common and severe […]
Wo Markttrends auf informierte Entscheidungen treffen
Headline
Tag: IBAT Inhibitors
Back To Top